Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

2.

Optimal antimalarial dose regimens for chloroquine in pregnancy based on population pharmacokinetic modelling.

Salman S, Baiwog F, Page-Sharp M, Kose K, Karunajeewa HA, Mueller I, Rogerson SJ, Siba PM, Ilett KF, Davis TME.

Int J Antimicrob Agents. 2017 Oct;50(4):542-551. doi: 10.1016/j.ijantimicag.2017.05.011. Epub 2017 Jun 29.

PMID:
28669839
3.

Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic Modeling.

Salman S, Baiwog F, Page-Sharp M, Griffin S, Karunajeewa HA, Mueller I, Rogerson SJ, Siba PM, Ilett KF, Davis TME.

Antimicrob Agents Chemother. 2017 Apr 24;61(5). pii: e02291-16. doi: 10.1128/AAC.02291-16. Print 2017 May.

4.

How important is gametocyte clearance after malaria therapy?

Karunajeewa HA, Mueller I.

BMC Med. 2016 Jun 18;14:93. doi: 10.1186/s12916-016-0641-3.

5.

Parasite clearance after malaria therapy: staying a step ahead of drug resistance.

Karunajeewa HA.

BMC Med. 2015 Oct 2;13:251. doi: 10.1186/s12916-015-0486-1.

6.

Meningeal inflammation increases artemether concentrations in cerebrospinal fluid in Papua New Guinean children treated with intramuscular artemether.

Manning L, Laman M, Page-Sharp M, Salman S, Hwaiwhanje I, Morep N, Siba P, Mueller I, Karunajeewa HA, Davis TM.

Antimicrob Agents Chemother. 2011 Nov;55(11):5027-33. doi: 10.1128/AAC.00375-11. Epub 2011 Aug 22.

7.

Characterization of treatment failure in efficacy trials of drugs against Plasmodium vivax by genotyping neutral and drug resistance-associated markers.

Barnadas C, Koepfli C, Karunajeewa HA, Siba PM, Davis TM, Mueller I.

Antimicrob Agents Chemother. 2011 Sep;55(9):4479-81. doi: 10.1128/AAC.01552-10. Epub 2011 Jun 27.

8.

Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea.

Davis WA, Clarke PM, Siba PM, Karunajeewa HA, Davy C, Mueller I, Davis TM.

Bull World Health Organ. 2011 Mar 1;89(3):211-20. doi: 10.2471/BLT.10.084103. Epub 2011 Feb 1.

9.

Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.

Manning L, Laman M, Edoni H, Mueller I, Karunajeewa HA, Smith D, Hwaiwhanje I, Siba PM, Davis TM.

PLoS Negl Trop Dis. 2011 Jan 4;5(1):e932. doi: 10.1371/journal.pntd.0000932.

10.

Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy.

Karunajeewa HA, Salman S, Mueller I, Baiwog F, Gomorrai S, Law I, Page-Sharp M, Rogerson S, Siba P, Ilett KF, Davis TM.

Antimicrob Agents Chemother. 2010 Mar;54(3):1186-92. doi: 10.1128/AAC.01269-09. Epub 2010 Jan 19.

11.

In vitro sensitivity of Plasmodium falciparum to conventional and novel antimalarial drugs in Papua New Guinea.

Wong RP, Lautu D, Tavul L, Hackett SL, Siba P, Karunajeewa HA, Ilett KF, Mueller I, Davis TM.

Trop Med Int Health. 2010 Mar;15(3):342-9. doi: 10.1111/j.1365-3156.2009.02463.x. Epub 2010 Jan 11.

12.

CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess.

von Ahsen N, Tzvetkov M, Karunajeewa HA, Gomorrai S, Ura A, Brockmöller J, Davis TM, Mueller I, Ilett KF, Oellerich M.

Int J Mol Epidemiol Genet. 2010 Aug 18;1(4):310-9.

13.

Investigation of reproductive toxicity of piperaquine in mice.

Batty KT, Moore BR, Stirling V, Ilett KF, Page-Sharp M, Shilkin KB, Mueller I, Rogerson SJ, Karunajeewa HA, Davis TM.

Reprod Toxicol. 2010 Apr;29(2):206-13. doi: 10.1016/j.reprotox.2009.10.013. Epub 2009 Nov 3.

PMID:
19892009
14.

Pharmacokinetic properties of azithromycin in pregnancy.

Salman S, Rogerson SJ, Kose K, Griffin S, Gomorai S, Baiwog F, Winmai J, Kandai J, Karunajeewa HA, O'Halloran SJ, Siba P, Ilett KF, Mueller I, Davis TM.

Antimicrob Agents Chemother. 2010 Jan;54(1):360-6. doi: 10.1128/AAC.00771-09. Epub 2009 Oct 26.

15.

Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women.

Karunajeewa HA, Salman S, Mueller I, Baiwog F, Gomorrai S, Law I, Page-Sharp M, Rogerson S, Siba P, Ilett KF, Davis TM.

Antimicrob Agents Chemother. 2009 Oct;53(10):4368-76. doi: 10.1128/AAC.00335-09. Epub 2009 Jul 20.

16.

A trial of combination antimalarial therapies in children from Papua New Guinea.

Karunajeewa HA, Mueller I, Senn M, Lin E, Law I, Gomorrai PS, Oa O, Griffin S, Kotab K, Suano P, Tarongka N, Ura A, Lautu D, Page-Sharp M, Wong R, Salman S, Siba P, Ilett KF, Davis TM.

N Engl J Med. 2008 Dec 11;359(24):2545-57. doi: 10.1056/NEJMoa0804915. Epub 2008 Dec 8.

17.

Toxicology and pharmacokinetics of piperaquine in mice.

Batty KT, Moore BR, Stirling V, Ilett KF, Page-Sharp M, Shilkin KB, Mueller I, Karunajeewa HA, Davis TM.

Toxicology. 2008 Jul 10;249(1):55-61. doi: 10.1016/j.tox.2008.04.004. Epub 2008 Apr 16.

PMID:
18502018
18.

Transfer of chloroquine and desethylchloroquine across the placenta and into milk in Melanesian mothers.

Law I, Ilett KF, Hackett LP, Page-Sharp M, Baiwog F, Gomorrai S, Mueller I, Karunajeewa HA, Davis TM.

Br J Clin Pharmacol. 2008 May;65(5):674-9. doi: 10.1111/j.1365-2125.2008.03111.x. Epub 2008 Feb 15.

19.

Pharmacokinetics and efficacy of piperaquine and chloroquine in Melanesian children with uncomplicated malaria.

Karunajeewa HA, Ilett KF, Mueller I, Siba P, Law I, Page-Sharp M, Lin E, Lammey J, Batty KT, Davis TM.

Antimicrob Agents Chemother. 2008 Jan;52(1):237-43. Epub 2007 Oct 29.

20.

Rectal administration of artemisinin derivatives for the treatment of malaria.

Karunajeewa HA, Manning L, Mueller I, Ilett KF, Davis TM.

JAMA. 2007 Jun 6;297(21):2381-90. Review.

PMID:
17551131
21.

Caregivers' acceptance of using artesunate suppositories for treating childhood malaria in Papua New Guinea.

Hinton RL, Auwun A, Pongua G, Oa O, Davis TM, Karunajeewa HA, Reeder JC.

Am J Trop Med Hyg. 2007 Apr;76(4):634-40.

PMID:
17426162
22.

Role of P glycoprotein in absorption of novel antimalarial drugs.

Crowe A, Ilett KF, Karunajeewa HA, Batty KT, Davis TM.

Antimicrob Agents Chemother. 2006 Oct;50(10):3504-6. Epub 2006 Aug 17.

23.

In vitro interactions between piperaquine, dihydroartemisinin, and other conventional and novel antimalarial drugs.

Davis TM, Hamzah J, Ilett KF, Karunajeewa HA, Reeder JC, Batty KT, Hackett S, Barrett PH.

Antimicrob Agents Chemother. 2006 Aug;50(8):2883-5.

24.

Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea.

Karunajeewa HA, Reeder J, Lorry K, Dabod E, Hamzah J, Page-Sharp M, Chiswell GM, Ilett KF, Davis TM.

Antimicrob Agents Chemother. 2006 Mar;50(3):968-74.

25.

Artemisinin-based combination therapies for uncomplicated malaria.

Davis TM, Karunajeewa HA, Ilett KF.

Med J Aust. 2005 Feb 21;182(4):181-5. Review.

PMID:
15720175
26.

Piperaquine: a resurgent antimalarial drug.

Davis TM, Hung TY, Sim IK, Karunajeewa HA, Ilett KF.

Drugs. 2005;65(1):75-87. Review.

PMID:
15610051
27.

Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.

Karunajeewa HA, Ilett KF, Dufall K, Kemiki A, Bockarie M, Alpers MP, Barrett PH, Vicini P, Davis TM.

Antimicrob Agents Chemother. 2004 Aug;48(8):2966-72.

28.

Safety and therapeutic efficacy of artesunate suppositories for treatment of malaria in children in Papua New Guinea.

Karunajeewa HA, Kemiki A, Alpers MP, Lorry K, Batty KT, Ilett KF, Davis TM.

Pediatr Infect Dis J. 2003 Mar;22(3):251-6.

PMID:
12634587
29.

Hydatid disease invading the inferior vena cava: successful combined medical and surgical treatment.

Karunajeewa HA, Jones RM, Hardy KJ, Buxton BF, Richards MJ.

ANZ J Surg. 2002 Feb;72(2):159-60. No abstract available.

PMID:
12074072
30.

Predictive value of personal recall of chicken pox infection: implications for the use of varicella vaccine.

Karunajeewa HA, Kelly HA.

Med J Aust. 2001 Feb 5;174(3):153. No abstract available.

PMID:
11247626

Supplemental Content

Loading ...
Support Center